InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD (Nasdaq: NSPR) said its Compensation Committee approved inducement grants for six new non-executive employees totaling 91,161 shares of restricted stock, dated June 12, 2026, under Nasdaq Rule 5635(c)(4). The awards are under the 2024 Inducement Plan and vest over three years, subject to continued employment.
How this was made
The 30-second read
Why it matters
The inducement grants create a small potential dilution over a 3-year vesting schedule but do not change product, trial, or regulatory status in the article.
Market read
A compliance-driven equity award disclosure; expect limited trading impact absent other catalysts.
What to watch
The press release reiterates major recall/going-concern risk factors in boilerplate; traders should not over-weight the inducement grant versus the larger recall/liquidity narrative.
Background
InspireMD uses an inducement plan for equity awards to new hires outside its existing equity incentive plan, complying with Nasdaq Listing Rule 5635(c)(4).
Ticker impact
InspireMD approved inducement grants for six new non-executive employees—91,161 restricted shares—under Nasdaq Rule 5635(c)(4).
Likely limited near-term impact; any move would be more sentiment/flow-driven than fundamentals.
The disclosure is a standard Nasdaq inducement-grant mechanism with no new clinical, regulatory, or commercial milestone; share count is small relative to typical market caps, and no cash/financing terms are provided.
Market effects
Minimal read-across for medtech/stent peers; this is an internal HR equity award rather than a product/regulatory event.
None indicated.
None indicated.
Counterpoint
If the market is focused on liquidity/going-concern risk, equity inducement activity can be interpreted as ongoing hiring/retention rather than distress—supporting a neutral stance.
Key entities
- companyInspireMD, Inc.
Developer of the CGuard Prime carotid stent system; announced inducement restricted-stock grants for new non-executive employees.
- regulationNasdaq Listing Rule 5635(c)(4)
Rule permitting inducement equity awards outside the company’s existing equity incentive plan.
